Christopher Mills - SunLink Health Independent Director
| SSY Stock | USD 1.08 0.06 5.88% |
Director
Mr. Christopher Harwood Bernard Mills is Independent Director of SunLink Health Systems, Inc. He is a Director and the Chief Investment Officer of Harwood Capital Management and has served in such capacity since October 30, 2011. Mr. Mills also serves as the Managing DirectorInvestment Manager of North Atlantic Smaller Companies Investment Trust plc and Trident North Atlantic, positions he has held since 1998. From January 1993 until October 2011, Mr. Mills was a Director and the Chief Investment Officer of J. O. Hambro. From 1984 to 1993 Mr. Mills was a Director of MIM Management Limited. Mr. Mills was deemed qualified to serve on the board for the reasons set forth above under Director Qualifications, including his business experience set forth herein. since 2007.
| Age | 67 |
| Tenure | 18 years |
| Phone | 770 933 7000 |
| Web | https://www.sunlinkhealth.com |
Christopher Mills Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Mills against SunLink Health stock is an integral part of due diligence when investing in SunLink Health. Christopher Mills insider activity provides valuable insight into whether SunLink Health is net buyers or sellers over its current business cycle. Note, SunLink Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell SunLink Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Mills over three months ago Acquisition by Christopher Mills of 10000 shares of SunLink Health at 1.38 subject to Rule 16b-3 | ||
Christopher Mills over three months ago Disposition of 30912 shares by Christopher Mills of SunLink Health at 1.957 subject to Rule 16b-3 | ||
Christopher Mills over six months ago Disposition of 221326 shares by Christopher Mills of SunLink Health at 2.3155 subject to Rule 16b-3 | ||
Christopher Mills over six months ago Disposition of 44308 shares by Christopher Mills of SunLink Health at 2.3318 subject to Rule 16b-3 |
SunLink Health Management Efficiency
The company has Return on Asset of (0.0954) % which means that on every $100 spent on assets, it lost $0.0954. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1476) %, meaning that it generated no profit with money invested by stockholders. SunLink Health's management efficiency ratios could be used to measure how well SunLink Health manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0954 |
SunLink Health Systems Leadership Team
Elected by the shareholders, the SunLink Health's board of directors comprises two types of representatives: SunLink Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SunLink. The board's role is to monitor SunLink Health's management team and ensure that shareholders' interests are well served. SunLink Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SunLink Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| C Ford, Independent Director | ||
| James Mulligan, General Emeritus | ||
| Sheila Brockman, Vice President | ||
| Mark Stockslager, Chief Financial Officer, Principal Accounting Officer | ||
| Theresa Mota, Secretary | ||
| Byron CPA, LLC ScriptsRX | ||
| Gene Burleson, Independent Director | ||
| Karen Brenner, Independent Director | ||
| Howard Turner, Independent Director | ||
| Steven Baileys, Independent Director | ||
| Christopher Mills, Independent Director | ||
| Byron Finn, President of SunLink ScriptsRx, LLC. | ||
| Robert Thornton, Executive Chairman, CEO and President and Chairman of Executive Committee | ||
| Neal Miller, Inc Technology |
SunLink Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SunLink Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0954 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.15) % | ||||
| Current Valuation | (439.58 K) | ||||
| Shares Outstanding | 7.04 M | ||||
| Shares Owned By Insiders | 26.60 % | ||||
| Shares Owned By Institutions | 13.45 % | ||||
| Number Of Shares Shorted | 17.88 K | ||||
| Price To Earning | 3.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for SunLink Stock Analysis
When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.